Arvinas (ARVN) Total Current Liabilities (2017 - 2026)

Arvinas (ARVN) recorded quarterly Total Current Liabilities of $115.9 million in Q1 2026, down 18.67% quarter-over-quarter from $142.5 million in Q4 2025, and down 45.84% on a YoY basis from $214.0 million in Q1 2025.

Arvinas (ARVN) Total Current Liabilities (2017 - 2026) Analysis & Trends

Arvinas' Total Current Liabilities history runs 10 years deep, the most recent figure standing at $115.9 million for Q1 2026.

  • In Q1 2026, Total Current Liabilities fell 45.84% year-over-year to $115.9 million; the TTM figure through Mar 2026 stood at $115.9 million (down 45.84% YoY), while the FY2025 annual figure was $142.5 million, down 37.99% from the prior year.
  • Total Current Liabilities was $115.9 million for Q1 2026 at Arvinas, down from $142.5 million in the prior quarter.
  • In the past five years, Total Current Liabilities ranged from a high of $347.2 million in Q2 2024 to a low of $115.9 million in Q1 2026.
  • Historically, Total Current Liabilities has averaged $238.2 million across 5 years, with a median of $240.8 million in 2024.
  • The sharpest annual moves came in 2022 and 2025: Total Current Liabilities jumped 489.52% in 2022, then tumbled 54.55% in 2025.
  • A 5-year view of Total Current Liabilities shows it stood at $295.1 million in 2022, then retreated by 12.88% to $257.1 million in 2023, then dropped by 10.62% to $229.8 million in 2024, then plunged by 37.99% to $142.5 million in 2025, then fell by 18.67% to $115.9 million in 2026.
  • The last three Total Current Liabilities figures came in at $115.9 million (Q1 2026), $142.5 million (Q4 2025), and $144.9 million (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Current Liabilities (Qtr)
1 Alterity Therapeutics 925,601.88 Bn 925,601.85 Bn - 1.70 Mn
2 Belite Bio 58,560.00 Bn 58,560.00 Bn - -
3 Quantum Biopharma 17,284.41 Bn 17,284.40 Bn - 16.35 Mn
4 Legend Biotech 2,809.00 Bn 2,808.71 Bn 242.10 Mn 636.40 Mn
5 Evaxion A 1,334.43 Bn 1,334.42 Bn - -
6 Akari Therapeutics 1,312.27 Bn 1,312.26 Bn - 13.42 Mn
7 Psyence Biomedical 212.16 Bn 212.16 Bn - -
8 Vertex Pharmaceuticals 114.83 Bn 107.58 Bn 2.59 Bn 3.88 Bn
9 Abivax 91.96 Bn 91.96 Bn - 72.86 Mn
10 Arvinas 492.16 Mn -122.74 Mn - 115.90 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 115.90 Mn
Dec 31, 2025 142.50 Mn
Sep 30, 2025 144.90 Mn
Jun 30, 2025 157.80 Mn
Mar 31, 2025 214.00 Mn
Dec 31, 2024 229.80 Mn
Sep 30, 2024 275.90 Mn
Jun 30, 2024 347.20 Mn
Mar 31, 2024 240.80 Mn
Dec 31, 2023 257.10 Mn
Sep 30, 2023 317.30 Mn
Jun 30, 2023 306.90 Mn
Mar 31, 2023 282.90 Mn
Dec 31, 2022 295.10 Mn
Sep 30, 2022 244.60 Mn
Jun 30, 2022 238.20 Mn
Mar 31, 2022 238.00 Mn
Dec 31, 2021 261.70 Mn
Sep 30, 2021 182.51 Mn
Jun 30, 2021 41.82 Mn